Amended: Naturally Splendid Health Canada Grants No Objection Letter to Proceed with COVID-19 Phase 2 Clinical Trial Jul 29, 2020 Life Science
Health Canada Grants No Objection Letter to Proceed with COVID-19 Phase 2 Clinical Trial Jul 29, 2020 Life Science
Healthcare Roundup – Moderna floating COVID-19 vaccine price up to $60 per course, Pfizer to seek FDA emergency use nod for COVID-19 vaccine Jul 29, 2020 Life Science
Healthcare Roundup – Large-scale study Moderna COVID-19 vaccine to be fully enrolled, Pfizer, BioNTech rise Jul 27, 2020 Life Science
Healthcare Roundup –Feds stumble with famotidine study in COVID-19, Trump signs orders to trim U.S. drug prices Jul 24, 2020 Life Science
Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO® Jul 24, 2020 Life Science
Healthcare Roundup – Novavax inks manufacturing deal for COVID-19 vaccine, Israel in talks to buy 4M doses of Arcturus COVID-19 vaccine Jul 24, 2020 Life Science
Healthcare Roundup – Pfizer, BioNTech ink deal with U.S. government, COVID-19 vaccine makers have different plans on pricing Jul 22, 2020 Life Science
Healthcare Roundup – Gilead secures stake in cancer immunotherapy developer Tizona, BioNTech selling shares Jul 22, 2020 Life Science
Healthcare Roundup – Novavax to present vaccine progress, Mask names on the move on presidential support Jul 20, 2020 Life Science
Healthcare Roundup – Slow turnaround times plague COVID-19 test sites, EU in talks with Moderna and others for COVID-19 vaccine supply Jul 17, 2020 Life Science
Healthcare Roundup – $75B to fix “flawed” U.S. COVID-19 testing, J&J on go with early-stage study of COVID-19 vaccine candidate Jul 17, 2020 Life Science
Healthcare Roundup – More positive news on the COVID-19 vaccine front, Oxford vaccine produces “double defence” against SARS-CoV-2 Jul 16, 2020 Life Science
Healthcare Roundup – Moderna coronavirus vaccine induces immune response, Osmotica completes round trip after FDA nod-stoked rally Jul 14, 2020 Life Science
Replicel Announces Update on Filing of Annual and Interim Financial Statements and MD&A Due to COVID-19 Related Delays Jul 13, 2020 Life Science
